2m 2m 2m 2m 2m 2m 2m
Pacira BioScienc (PCRX)
NASDAQ
$22.31+$0.05 (+0.25%)
Price as of Jun 03, 2026 5:18 PM EDT- $913.7MMarket Cap
- -15.72%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Pacira BioScienc (PCRX)
$22.31+$0.05 (+0.25%)
PCRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $22.25 | ||
Change | -$0.71 (-3.09%) | ||
Open | $22.96 | ||
High | $23.16 | ||
Low | $22.21 | ||
Previous Close | $22.96 | ||
Volume | 345,434 | ||
30-Day Average Volume | 525,354 | ||
1-Week Change | -8.66% | ||
1-Month Change | -8.96% | ||
1-Year Change | -15.72% | ||
3-Year Change | -43.08% | ||
5-Year Change | -64.09% | ||
Fundamentals | |||
Shares Outstanding | 39.3M | ||
Total Assets | $1.2B | ||
Market Cap | $913.7M | ||
Enterprise Value | $1.2B | ||
Period: QTR TTM FY | |||
Revenue | $177.4M | ||
Net Income | $2.9M | ||
Free Cash Flow | $23.0M | ||
EBIT | $8.7M | ||
EBITDA | $30.0M | ||
Net Working Capital | $406.2M | ||
EPS | $0.07 | ||
Enterprise Value/EBITDA | 41 | ||
Enterprise Value/Revenue | 7 | ||
P/B | 1 | ||
P/E | 332 | ||
PEG | 4 | ||
Price/Free Cash Flow | 40 | ||
Price/Operating Cash Flow | 36 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue